Innoviva (INVA) Return on Sales Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.00 |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -42.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.00 |
| Dec 31, 2025 | -3.00 |
| Sep 30, 2025 | -176.00 |
| Jun 30, 2025 | -11.00 |
| Mar 31, 2025 | -31.00 |
| Dec 31, 2024 | -2.00 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -95.00 |
| Mar 31, 2024 | -65.00 |
| Dec 31, 2023 | -153.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 43.00 |
| Dec 31, 2022 | -11.00 |
| Sep 30, 2022 | 176.00 |
| Jun 30, 2022 | 11.00 |
| Mar 31, 2022 | 30.00 |
| Dec 31, 2021 | -9.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 94.00 |
| Mar 31, 2021 | 102.00 |
| Dec 31, 2020 | 148.00 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | 1.00 |
| Mar 31, 2020 | 1.00 |
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Mar 31, 2019 | 1.00 |
| Mar 31, 2018 | 3.00 |
| Dec 31, 2017 | 10.00 |
| Sep 30, 2017 | 33.00 |
| Jun 30, 2017 | 47.00 |
| Mar 31, 2017 | 66.00 |
| Dec 31, 2016 | 28.00 |
| Sep 30, 2016 | 91.00 |
| Jun 30, 2016 | 27.00 |
| Mar 31, 2016 | 20.00 |
| Mar 31, 2015 | -3.00 |
| Dec 31, 2014 | -3.00 |
| Sep 30, 2014 | -28.00 |
| Jun 30, 2014 | -43.00 |
| Mar 31, 2014 | -62.00 |